Avandia Researchers’ Financial Ties Questioned

A new review of studies on the controversial diabetes drug Avandia finds that most of the researchers who reported positive results had financial ties to pharmaceutical companies, but it’s not clear if being paid by drug makers directly leads to supportive research.